Latest Market Validation News

IDT Australia reports a sharp turnaround in FY26 with a 66% reduction in net loss and an 85% improvement in EBITDA, underpinned by a strategic reset and targeted investments in manufacturing capabilities.

Resouro Strategic Metals has filed a comprehensive NI 43-101 Technical Report that underpins its Preliminary Economic Assessment for the Tiros Titanium and Rare Earths Project in Brazil, confirming robust economics and a capital-efficient staged development strategy.

Black Rock Mining has secured an extension to its US$204 million credit facility to November 2026, providing crucial runway to finalise equity funding for its Mahenge Graphite Project. Early works are nearing completion, positioning the project for construction pending full funding and Final Investment Decision.

Augustus Minerals reported promising gold assay results at its Music Well project, alongside progress in Papua New Guinea exploration and a $2.5 million capital raise featuring Gold Fields’ backing.

ECS Botanics plans to introduce two 2g all-in-one vape products under its OzSun brand in mid-August 2026, expanding its higher-margin B2C portfolio with a capital-efficient supply model.

Green360 Technologies has locked in its inaugural commercial supply contract with Holcim Australia for up to 4,800 tonnes of its MKX-CC low-carbon cement replacement, marking its shift from development to commercial sales amid tightening supplementary cementitious material supplies.

Locate Technologies’ Q4 FY26 update highlights a 54% surge in Locate2u revenue to NZ$1.20 million, driving normalised EBITDA into positive territory. AI integration accelerated product development and customer onboarding, while capital moves included a share buyback and royalty conversion.

PainChek has received a $1.123 million R&D tax incentive refund for FY2025, reinforcing its cash reserves and underpinning ongoing development of AI pain assessment algorithms and US market validation.

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

Klevo Rewards has successfully completed a 14-day commercial trial of its stablecoin transaction platform, generating approximately USD 1.22 million in gross revenue and validating its payment capabilities.

AdAlta has met a key US$1 million milestone payment under its China collaboration, gaining critical clinical data and securing proprietary materials for Australian manufacturing of its lead CAR-T therapy BZDS1901.

Pacific Edge has secured NZ$36.1 million through a combination of a NZ$25.4 million placement and a significantly oversubscribed retail offer, reinforcing its strategic position to expand the Cxbladder cancer diagnostic platform.